Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
28.44
+1.12 (4.10%)
At close: Aug 1, 2025, 4:00 PM
28.24
-0.20 (-0.69%)
After-hours: Aug 1, 2025, 7:50 PM EDT
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$86.94
Upside
+205.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +181.29% | Jul 28, 2025 |
| Wedbush | Wedbush | Hold Maintains $35 → $34 | Hold | Maintains | $35 → $34 | +19.55% | Jul 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +93.39% | Jul 14, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $88 → $65 | Buy | Maintains | $88 → $65 | +128.55% | Jul 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $64 | Strong Buy | Reiterates | $64 | +125.04% | Jun 20, 2025 |
| William Blair | William Blair | Buy Initiates $65 | Buy | Initiates | $65 | +128.55% | May 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $64 → $65 | Buy | Maintains | $64 → $65 | +128.55% | May 9, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $104 → $117 | Buy | Maintains | $104 → $117 | +311.39% | Mar 27, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $140 → $115 | Buy | Maintains | $140 → $115 | +304.36% | Mar 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $118 | Buy | Reiterates | $118 | +314.91% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +234.04% | Feb 18, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $121 → $136 | Strong Buy | Maintains | $121 → $136 | +378.20% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $95 | Strong Buy | Reiterates | $95 | +234.04% | Feb 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $118 | Buy | Reiterates | $118 | +314.91% | Jan 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $135 → $140 | Buy | Maintains | $135 → $140 | +392.26% | Jan 13, 2025 |
| Wedbush | Wedbush | Hold Reiterates $46 → $48 | Hold | Reiterates | $46 → $48 | +68.78% | Jan 13, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.